Aquilo Capital Management, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aquilo Capital Management, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$19,037,900
-32.9%
379,090
-15.6%
17.25%
+9.7%
Q2 2023$28,375,978
+1.3%
448,987
-27.9%
15.72%
+35.4%
Q1 2023$28,021,077
+9.9%
622,829
+7.1%
11.61%
+21.3%
Q4 2022$25,487,256
-26.2%
581,768
+11.0%
9.57%
-23.1%
Q3 2022$34,544,000
-4.6%
524,268
-26.8%
12.45%
+0.8%
Q2 2022$36,192,000
-27.5%
716,539
-8.3%
12.35%
+68.3%
Q1 2022$49,925,000
-27.8%
781,539
+21.1%
7.34%
-6.4%
Q4 2021$69,144,000
+28.9%
645,539
+23.7%
7.84%
-19.5%
Q3 2021$53,633,000
+35.9%
521,673
+16.3%
9.74%
-5.0%
Q2 2021$39,451,000
-4.1%
448,512
+6.0%
10.25%
+37.9%
Q1 2021$41,129,000
-3.5%
423,012
+11.3%
7.43%
-16.1%
Q4 2020$42,618,000
+19.2%
380,012
-1.5%
8.86%
+134.0%
Q3 2020$35,757,000
+45.5%
385,727
+22.4%
3.78%
-23.6%
Q2 2020$24,572,000
+902.5%
315,029
+928.9%
4.96%
+356.7%
Q1 2019$2,451,00030,6181.08%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders